Pharma Journalist -

Mylan N.V. announced that Mylan has agreed to the terms of a global settlement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. in relation to patents for Herceptin® (trastuzumab),…
Read More...

Charles River Laboratories International, Inc., a leading early-stage contract research organization (CRO), today announced that it has extended its longstanding, strategic, integrated…
Read More...

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful…
Read More...

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology, is pleased to announce the successful initial…
Read More...

Mylan N.V., announced the U.S. launch of Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, a generic version of Pfizer's Pristiq® Tablets. Mylan received final approval from…
Read More...

BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for phenotypic screening assays.  With…
Read More...

Pharnext SA, a French biopharmaceutical company developing an advanced portfolio of products in the field of neurodegenerative diseases, today announced a research and development…
Read More...

Amring Pharmaceuticals Inc., a generic pharmaceutical company, announced today that it acquired six ANDAs from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture…
Read More...

Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it completed the sale to Ferring International…
Read More...

Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European…
Read More...